Cite
Topically Applied Miltefosine (Hexadecylphosphocholine) in Patients with Skin-Metastasized Breast Cancer. A Phase II Study.
MLA
linger, C., et al. “Topically Applied Miltefosine (Hexadecylphosphocholine) in Patients with Skin-Metastasized Breast Cancer. A Phase II Study.” Onkologie, vol. 16, no. 3, Jan. 1993, pp. 170–73. EBSCOhost, https://doi.org/10.1159/000218252.
APA
linger, C., Herrmann, R., Berdel, W. E., Kleeberg, U. R., Gatzemeier, U., Illiger, H. J., Wander, H. E., Westerhausen, M., Becher, R., Bremer, K., Rieche, K., Essers, U., Queißer, W., Heidemann, E., Fiebig, H. H., Possinger, K., Jourdain-Madl, B., Heim, M. E., & Edler, L. (1993). Topically Applied Miltefosine (Hexadecylphosphocholine) in Patients with Skin-Metastasized Breast Cancer. A Phase II Study. Onkologie, 16(3), 170–173. https://doi.org/10.1159/000218252
Chicago
linger, C., R. Herrmann, W.E. Berdel, U.R. Kleeberg, U. Gatzemeier, H.J. Illiger, H.E. Wander, et al. 1993. “Topically Applied Miltefosine (Hexadecylphosphocholine) in Patients with Skin-Metastasized Breast Cancer. A Phase II Study.” Onkologie 16 (3): 170–73. doi:10.1159/000218252.